Walleye Trading
TCRT icon

Walleye Trading’s Alaunos Therapeutics TCRT Stock Holding History

Walleye Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– – – 4575
2017
Q2 		– Hold
0
– – – 4926
2016
Q4 		– Sell
-182
Closed -$154K – 5176
2016
Q3 		$154K Buy
+182
New +$146K ﹤0.01% 2998

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's TCRT Position: Q3 2017 in Review

Walleye Trading held its Alaunos Therapeutics (TCRT) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4575.

Walleye Trading first reported a position in TCRT in Q3 2016 and has held it in 1 quarter since. The position peaked at $154K in Q3 2016. 122 funds tracked by Wall St. Rank hold TCRT as of Q3 2017.

  • Walleye Trading held 0 shares of Alaunos Therapeutics worth $0 as of Q3 2017.
  • Walleye Trading left its Alaunos Therapeutics share count unchanged in Q3 2017.
  • Alaunos Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q3 2017, its #4575 holding.
  • Walleye Trading first reported a position in Alaunos Therapeutics in Q3 2016 and has held it in 1 quarter since.
  • Walleye Trading's Alaunos Therapeutics position peaked at $154K in Q3 2016.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2017.

Based on Walleye Trading's 13F filing for Q3 2017, filed 14 Nov 2017.